Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconTRVITrevi Therapeutics$2.01bnn/an/a
us flag iconTYRATyra Biosciences$1.96bnn/an/a
us flag iconVRDNViridian Therapeutics$1.95bnn/an/a
us flag iconANABVAnaptysBio$1.94bnn/an/a
us flag iconOCSOculis Holding AG$1.92bnn/an/a
us flag iconSIONSionna Therapeutics$1.89bnn/an/a
ca flag iconBLUBELLUS HealthCA$2.47bnn/an/a
us flag iconSTOKStoke Therapeutics$1.85bnn/an/a
us flag iconZYMEZymeworks$1.85bnn/an/a
us flag iconFUSNFusion Pharmaceuticals$1.83bnn/an/a
us flag iconNRIXNurix Therapeutics$1.81bnn/an/a
us flag iconINBXInhibrx$1.79bnn/an/a
us flag iconAMAMAmbrx Biopharma$1.76bnn/an/a
us flag iconDVAXDynavax Technologies$1.76bn295.24n/a
us flag iconANABAnaptysBio$1.76bnn/an/a
us flag iconRAPPRapport Therapeutics$1.76bnn/an/a
us flag iconSNDXSyndax Pharmaceuticals$1.75bnn/an/a
us flag iconNTLAIntellia Therapeutics$1.73bnn/an/a
us flag iconCAPRCapricor Therapeutics$1.71bnn/an/a
us flag iconAGIOAgios Pharmaceuticals$1.71bnn/an/a